⌘K

byHone Systems Hone

MENU

Market Intelligence

Timely disclosures Statutory filings News Filing Briefings Threads Shared themes

Komori×Hone Systems

Put AI to work in your business.Hone Systems builds AI into your day-to-day operations and keeps it running. Everything we build is yours.

Book 30 minutes →About Hone

What Komori does

Loading

HomeWatch Notifications

Discontinuation of ASP0739 Cancer Development | Shared theme

⌘K

byHone Systems Hone

MENU

Market Intelligence

Timely disclosures Statutory filings News Filing Briefings Threads Shared themes

Komori×Hone Systems

Put AI to work in your business.Hone Systems builds AI into your day-to-day operations and keeps it running. Everything we build is yours.

Book 30 minutes →About Hone

What Komori does

ONE-WAYDated event · through FY2023

Discontinuation of ASP0739 Cancer Development

An individual drug development program involving the discontinuation of Phase I development of ASP0739 for cancer.

Companies1How many companies write about this.

Threads1One company can carry more than one thread here.

PeriodFY2023 →Last written FY2023

Directionhurts0 helps · 1 hurts · 0 flat

Loading

HomeWatch Notifications